| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ENSC | Common Stock | Award | +353,451 | 353,451 | 30 Jun 2021 | Direct | F1, F2 | |||
| transaction | ENSC | Common Stock | Award | +2,242,189 | 2,242,189 | 30 Jun 2021 | By Trust | F1, F3 |
| Id | Content |
|---|---|
| F1 | On June 30, 2021, pursuant to that certain Agreement and Plan of Merger dated January 31, 2021 (the "Merger Agreement") among Ensysce Biosciences, Inc. (f/k/a Leisure Acquisition Corp.) (the "Issuer"), EB Merger Sub, Inc., a Delaware corporation and wholly-owned, direct subsidiary of the Issuer ("Merger Sub"), and Ensysce Biosciences, Inc., a Delaware corporation ("Ensysce"), Merger Sub merged with and into Ensysce (the "Merger"), with Ensysce surviving as a wholly owned subsidiary of the Issuer. Pursuant to the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each share of Ensysce common stock was automatically converted into the right to receive a pro rata portion of 17,334,518 shares of the Issuer's common stock. |
| F2 | Represents the shares owned jointly with the Reporting Person's wife. |
| F3 | Represents the shares held by the trusts in which the Reporting Person has sole or shared voting and dispositive power. |